APLLTD.NSE Alembic Pharmaceuticals Ltd

The tentative approval by the US Food & Drug Administration (USFDA) was for Ribociclib tablets of strength 200 mg, Alembic Pharmaceuticals said in a regulatory filing.

The US drug regulator had inspected Alembic Pharma's oncology formulations (injectable and oral solid) unit at Panelav in Gujarat from February 28 to March 8

Semgalutide has almost 66 percent of the market share in the anti-obesity segment.

As the market advances, it is advisable to focus on risk management and have a selective approach while looking out for thematic movers amidst the ongoing sectoral rotation, Sameet Chavan said.